Excess total mortality in 2021 in Italy was about one third of that observed in 2020.
Journal
La Medicina del lavoro
ISSN: 0025-7818
Titre abrégé: Med Lav
Pays: Italy
ID NLM: 0401176
Informations de publication
Date de publication:
23 Dec 2021
23 Dec 2021
Historique:
received:
21
11
2021
accepted:
29
11
2021
entrez:
23
12
2021
pubmed:
24
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
Italy was severely hit by the Covid-19 pandemic with an excess of around 90,000 total deaths in 2020. Comparable data in 2021 are needed for monitoring the effects of the interventions adopted to control its spread and reduce the burden. This study estimates the excess mortality in Italy in the first eight months of 2021, with a focus on the working age population. Excess mortality was estimated as difference between the number of registered deaths and the expected deaths. Expected deaths in March-December 2020 and January-August 2021 were estimated separately by sex, through an over-dispersed Poisson regression model using mortality and population data for the period 2011-2019 (before the Covid-19 outbreak). The models included terms for calendar year, age group, a smooth function of week of the year and the natural logarithm of the population as offset term. Results: In the first eight months of 2021, we estimated 34,599 excess deaths (+7.9% of the expected deaths), of these 3667 were among individuals of working age (25-64 years). In this age group, mortality was 8.2% higher than expected with higher excesses among men (2972 deaths, +10.7%) than women (695 deaths, +4.1%). The excess deaths in the first eight months of 2021 account for about one third of that registered in 2020. Current data indicate that around 5000 excess deaths are expected by the end of the year, leading to a total excess for 2021 of around 40 thousand deaths. Despite the absence of influenza in January-March 2021, a relevant excess was also observed among the working age population.
Sections du résumé
BACKGROUND
BACKGROUND
Italy was severely hit by the Covid-19 pandemic with an excess of around 90,000 total deaths in 2020. Comparable data in 2021 are needed for monitoring the effects of the interventions adopted to control its spread and reduce the burden. This study estimates the excess mortality in Italy in the first eight months of 2021, with a focus on the working age population.
METHODS
METHODS
Excess mortality was estimated as difference between the number of registered deaths and the expected deaths. Expected deaths in March-December 2020 and January-August 2021 were estimated separately by sex, through an over-dispersed Poisson regression model using mortality and population data for the period 2011-2019 (before the Covid-19 outbreak). The models included terms for calendar year, age group, a smooth function of week of the year and the natural logarithm of the population as offset term. Results: In the first eight months of 2021, we estimated 34,599 excess deaths (+7.9% of the expected deaths), of these 3667 were among individuals of working age (25-64 years). In this age group, mortality was 8.2% higher than expected with higher excesses among men (2972 deaths, +10.7%) than women (695 deaths, +4.1%).
CONCLUSIONS
CONCLUSIONS
The excess deaths in the first eight months of 2021 account for about one third of that registered in 2020. Current data indicate that around 5000 excess deaths are expected by the end of the year, leading to a total excess for 2021 of around 40 thousand deaths. Despite the absence of influenza in January-March 2021, a relevant excess was also observed among the working age population.
Identifiants
pubmed: 34939614
doi: 10.23749/mdl.v112i6.12601
pmc: PMC8759051
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
414-421Références
Panminerva Med. 2021 Jan 25;:
pubmed: 33494569
Med Lav. 2020 Oct 31;111(5):351-353
pubmed: 33124605
Int J Epidemiol. 2021 Jan 23;49(6):1909-1917
pubmed: 33053172
Eur J Epidemiol. 2021 Feb;36(2):213-218
pubmed: 33495860
BMJ. 2021 May 19;373:n1137
pubmed: 34011491
Panminerva Med. 2021 Apr 28;:
pubmed: 33908730
N Engl J Med. 2020 May 21;382(21):e71
pubmed: 32369276
Front Public Health. 2021 Jul 16;9:669209
pubmed: 34336767
PLoS One. 2021 Jun 4;16(6):e0252454
pubmed: 34086762
Lancet. 2020 Sep 12;396(10253):e27-e28
pubmed: 32891216
PLoS One. 2020 Oct 9;15(10):e0240286
pubmed: 33035253